Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
NRC funding available for 1988
View through CrossRef
The National Research Council (NRC) is inviting applications from scientists and engineers who would like to receive funding under the NRC's Resident, Cooperative, and Postdoctoral Research Associateship Program in 1988. Each interested Ph.D. scientist can apply for $27,150 to $35,000 per year to conduct his or her own research at and on behalf of one of 28 host laboratories in the United States.Approximately 450 associateships will be awarded in 1988; each can be held for 1 or 2 years, although it may be possible for senior researchers to obtain shorter‐term grants. Most of the associateships are available to both U.S. and non‐U.S. nationals. Three competitions will be held for the associateships in 1988. The deadlines for postmarking of applications are January 15, 1988 (December 15, 1987 for National Aeronautics and Space Administration), April 15, 1988, and August 15, 1988.
Title: NRC funding available for 1988
Description:
The National Research Council (NRC) is inviting applications from scientists and engineers who would like to receive funding under the NRC's Resident, Cooperative, and Postdoctoral Research Associateship Program in 1988.
Each interested Ph.
D.
scientist can apply for $27,150 to $35,000 per year to conduct his or her own research at and on behalf of one of 28 host laboratories in the United States.
Approximately 450 associateships will be awarded in 1988; each can be held for 1 or 2 years, although it may be possible for senior researchers to obtain shorter‐term grants.
Most of the associateships are available to both U.
S.
and non‐U.
S.
nationals.
Three competitions will be held for the associateships in 1988.
The deadlines for postmarking of applications are January 15, 1988 (December 15, 1987 for National Aeronautics and Space Administration), April 15, 1988, and August 15, 1988.
Related Results
Pleurocidin-family cationic antimicrobial peptides are cytolytic for breast carcinoma cells and prevent growth of tumor xenografts
Pleurocidin-family cationic antimicrobial peptides are cytolytic for breast carcinoma cells and prevent growth of tumor xenografts
Abstract
Introduction
Cationic antimicrobial peptides (CAPs) defend against microbial pathogens; however, certain CAPs also exhibit ...
Outcomes of Transplant-Eligible Patients with Myelodysplastic Syndrome-Refractory Anemia with Excess Blasts Registered in a Prospective Observational Study: The JALSG-CS11-MDS-SCT
Outcomes of Transplant-Eligible Patients with Myelodysplastic Syndrome-Refractory Anemia with Excess Blasts Registered in a Prospective Observational Study: The JALSG-CS11-MDS-SCT
Abstract
Introduction: Allogeneic hematopoietic stem cell transplantation (allo-SCT) is the sole curative therapy for myelodysplastic syndromes (MDS). Several studie...
Comparison of Conventional Xrays with CT Based Approaches for Detection of Lytic Lesions in Multiple Myeloma
Comparison of Conventional Xrays with CT Based Approaches for Detection of Lytic Lesions in Multiple Myeloma
Background: Lytic bone lesions are one of the most common clinical characteristics of patients with multiple myeloma (MM) and identification of bone lesions help distinguish betwee...
Phase 2 Study of Tirabrutinib (ONO/GS-4059), a Second-Generation Bruton's Tyrosine Kinase Inhibitor, Monotherapy in Patients with Treatment-Naïve or Relapsed/Refractory Waldenström Macroglobulinemia
Phase 2 Study of Tirabrutinib (ONO/GS-4059), a Second-Generation Bruton's Tyrosine Kinase Inhibitor, Monotherapy in Patients with Treatment-Naïve or Relapsed/Refractory Waldenström Macroglobulinemia
BACKGROUND
Waldenström macroglobulinemia (WM) is a lymphoplasmacytic lymphoma in which bone marrow is infiltrated by immunoglobulin M (IgM)-producing clonal lymphopl...
Randomized Study of Digital Life Coaching during Autologous Stem Cell Transplantation
Randomized Study of Digital Life Coaching during Autologous Stem Cell Transplantation
Abstract
BACKGROUND: Autologous stem cell transplantation (ASCT) for multiple myeloma (MM) entails sudden life changes including acute symptom burden, changes in phy...
Trial in Progress: Phase I Open-Label Study of Metformin and Nelfinavir in Combination with Bortezomib in Patients with Relapsed and/or Refractory Multiple Myeloma
Trial in Progress: Phase I Open-Label Study of Metformin and Nelfinavir in Combination with Bortezomib in Patients with Relapsed and/or Refractory Multiple Myeloma
Abstract
Background:
GLUT4 inhibition is an attractive therapeutic option in multiple myeloma (MM) given the dependence of MM cells on glucose transpo...
The Backfit Rule’s Compliance Exception
The Backfit Rule’s Compliance Exception
The Backfit Rule, 10 CFR §50.109, requires the NRC staff to produce cost-benefit evaluations to justify any changes it may make in its positions, or any new requirements it might i...
Morphological and Mechanical Properties of Natural Rubber Compound/Poly(butylene succinate) Blend
Morphological and Mechanical Properties of Natural Rubber Compound/Poly(butylene succinate) Blend
Abstract
Biodegradable poly(butylene succinate) (PBS)/natural rubber compound (NRC) blend was melt mixed using a two-roll mill. A weight ratio of PBS/NRC was 100/0, ...